Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM65862
Volume:
10 |
7 |
Jul 2026
Pages:
1-12
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
Department Of Pharmacology
Kalyani Charitable Trust’s Ravindra Gambhirrao Sapkal College Of Pharmacy
In recent years, growing interest in plant-derived therapeutics has led to studies of medicinal plants with analgesic and anti-inflammatory activity. Azadirachta indica (Neem) and Holarrhena antidysenterica (Kutaj) have been used medicinally in Ayurvedic and Unani medicine for inflammatory conditions, pain and gastrointestinal diseases. The current review summarizes the phytochemical profiles, pharmacological effects, and understanding of both plants. A. indica contains high concentrations of limonoids, flavonoids, and phenolics that regulate inflammatory mediators such as prostaglandins, tumor necrosis factor-alpha (TNF-α), and interleukins, and exhibit antioxidant and immunomodulatory properties. The anti-inflammatory, anti-analgesic, and neuroprotective activity of H. antidysenterica is mediated by modulation of ion channels, enzymatic pathways, and immune responses, a property attributed to the presence of steroidal alkaloids such as conessine. The preclinical data show a dose-dependent anti-pain effect on paw edema and inflammatory markers, similar to that of well-known chemical analgesics at high doses. These phytochemicals are synergic and polypharmacological and are good candidates for alternative-based therapeutics. The review also highlights the importance of standardization of extraction, pharmacokinetic characterization, and clinical validation to guarantee the efficacy and safety of the use in human application.
KEYWORDS
Further studies are required to elucidate the pharmacokinetic parameters and the exact molecular mechanisms of these secondary metabolites to develop a standardized therapeutic guideline based on evidence from the developed research (Semwal et al., 2023, p. 1257019). In particular, incorporating pharmacokinetic/pharmacodynamic (PK/PD) parameters, including maximum plasma concentration (Cmax) and area under the concentration-time curve (AUC), will be crucial to defining a therapeutic window and facilitating clinical translatability (Tie et al., 2025, p. 1657842). Additionally, investigators need to focus on long-term safety monitoring and follow rigorous reporting guidelines, including the CONSORT statement, to confirm the benefit-risk balance of these medicinal products (Wang et al., 2022, p. 154591). Future studies are also required to include standardized microscopic analysis, physicochemical evaluation, and characterization of the chemical fingerprints of these herbal products to improve the authentication and reliability of each batch and ensure consistent efficacy (Noviana et al., 2022, p. 853038). Furthermore, understanding how the plant interacts with drugs is crucial because some compounds can affect the mechanisms by which traditional medicines are metabolized, potentially impacting patient safety (Balkrishna et al., 2024, p. 39). Furthermore, it remains an urgent need to translate these promising preclinical results into proven clinical practice through well-designed randomized controlled trials (Addissouky et al., 2023, p. 61; Attiq et al., 2017, p. 768).
1. Abba, A., & Dogara, A. M. (2021). Ethnomedicinal Survey of Plants used for Management of Inflammatory Diseases in Ringim Local Government, Jigawa State, Nigeria. Ethnobotany Research and Applications, 22. https://doi.org/10.32859/era.22.47.1-27 2. Addissouky, T. A., Ali, M. M. A., Sayed, I. E. T. E., & Wang, Y. (2023). Recent Advances in Diagnosing and Treating Helicobacter pylori through Botanical Extracts and Advanced Technologies. Archives of Pharmacology and Therapeutics, 5(1), 53–66. https://doi.org/10.33696/pharmacol.4.045 3. Aggarwal, B. B., Prasad, S., Reuter, S., Kannappan, R., Yadav, V. R., Park, B., Kim, J. H., Gupta, S. C., Phromnoi, K., Sundaram, C., Prasad, S., Chaturvedi, M. M., & Sung, B. (2011). Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach. Current Drug Targets, 12(11), 1595–1653. https://doi.org/10.2174/138945011798109464 4. Aggarwal, I., Upadhyay, S., & Kumar, A. (2025). PHARMACOLOGICAL EVALUATION OF COMBINED MIXTURE OF FRACTIONS FOR ANALGESIC AND ANTI-INFLAMMATORY POTENTIAL IN RODENT MODELS. Asian Journal of Pharmaceutical and Clinical Research, 143–146. https://doi.org/10.22159/ajpcr.2025v18i12.57268 5. Aladejana, E. B. (2023). Biological Properties of Polyherbal Formulations: A Review of their Antimicrobial, Anti-Inflammatory, Antioxidant, and Toxicological Activities. Pharmacognosy Journal, 15(5), 933–963. https://doi.org/10.5530/pj.2023.15.178 6. Alamry, K. A., Hussein, M. A., Khan, A., & Asiri, A. M. (2024). Anticoagulation activity of sulfated carboxymethyl cellulose/Azadirachta indica leaf powder-based bio-composite. RSC Advances, 14(30), 22017–22027. https://doi.org/10.1039/d4ra02893g 7. Alhazmi, H. A., Najmi, A., Javed, S. A., Sultana, S., Bratty, M. A., Makeen, H. A., Meraya, A. M., Ahsan, W., Mohan, S., Taha, M. M. E., & Khalid, A. (2021). Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19. Frontiers in Immunology, 12, 637553–637553. https://doi.org/10.3389/fimmu.2021.637553 8. Alyas, S., Zahra, N., Khadam, A., SULTANA, R., ZAHID, B., Tariq, R., Akhtar, R., RAFIQUE, H., & Ahmad, S. S. (2023). STUDY OF ANTI-INFLAMMATORY, ANTIPYRETIC AND ANALGESIC EFFECTS OF AZADIRACHTA INDICA LEAVES EXTRACT IN ALBINO RATS. Biological and Clinical Sciences Research Journal, 2023(1), 257–257. https://doi.org/10.54112/bcsrj.v2023i1.257 9. Alzohairy, M. A. (2016). Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evidence-Based Complementary and Alternative Medicine, 2016(1), 7382506–7382506. https://doi.org/10.1155/2016/7382506 10. Anis, M., Baig, S. G., Farrukh, U., Ahmad, F. M., Mansoor, N., & Mahmood, Z. A. (2026). Exploring The Therapeutic Potential Of A Polyherbal Combination For Pain And Inflammation. Pakistan Journal of Pharmaceutical Sciences, 39(3), 657–666. https://doi.org/10.36721/pjps.2026.39.3.reg.14596.1
Publication Date
7/6/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
1
Total views since publication
PDF Downloads
6
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...